Genetically predicted serum uric acid and pulmonary arterial hypertension: Mendelian randomization with an exploratory NHANES risk-burden analysis
Science Progress · 2026-04 · 109 (2)
DOI: 10.1177/00368504261463441 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Progress, online erschienen am 22.06.2026. Verfasst von Huabin He und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Jiujiang City Key Laboratory of Cell Therapy, Jiujiang First People's Hospital, Jiujiang, Jiangxi, China. Hauptthemen laut MEDLINE: Mendelian Randomization Analysis, Uric Acid, Pulmonary Arterial Hypertension. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
Serum uric acid (SUA) has been associated with cardiovascular and pulmonary vascular disease, but whether SUA has a causal role in pulmonary arterial hypertension (PAH) remains uncertain. This study aimed to evaluate the genetic association between SUA and PAH using Mendelian randomization (MR), with an exploratory population-based analysis in individuals with a higher PAH-related risk-factor burden.
Methods
We conducted two-sample MR using publicly available genome-wide association study (GWAS) summary statistics. The European-ancestry SUA dataset (GCST90014015) was used as the primary exposure dataset, and a cross-population SUA dataset (GCST90018977) was used as exploratory secondary evidence. PAH outcome data were obtained from the largest available PAH GWAS. Cross-sectional NHANES 2003-2018 data were used only as descriptive exploratory context based on a PAH-related risk-factor burden.
Results
Genetically predicted SUA was associated with higher PAH risk in the European primary analysis (GCST90014015: OR=1.31, 95% CI 1.03-1.68, P =0.028). The mixed-ancestry exploratory analysis showed a consistent direction of effect (GCST90018977: OR=1.52, 95% CI 1.16-2.00, P =0.003), but this estimate was not pooled with the European primary estimate and should not be interpreted as replication because of ancestry mismatch. Sensitivity analyses did not indicate substantial heterogeneity or horizontal pleiotropy. In NHANES, SUA was positively associated with a higher PAH-related risk-factor burden in exploratory logistic models (Model 2: OR=1.708, 95% CI 1.645-1.773, P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Jiujiang City Key Laboratory of Cell Therapy, Jiujiang First People's Hospital, Jiujiang, Jiangxi, China.
- Department of Rheumatology and Immunology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
- Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
- Department of Gastroenterology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
ORCID-Profile: Huangxin Zhu
Zitieren
APA
He, H., Liu, Z., Yu, Q., Fu, Q., & Zhu, H. (2026). Genetically predicted serum uric acid and pulmonary arterial hypertension: Mendelian randomization with an exploratory NHANES risk-burden analysis. Science Progress, 109(2). https://doi.org/10.1177/00368504261463441
Vancouver
He H, Liu Z, Yu Q, Fu Q, Zhu H. Genetically predicted serum uric acid and pulmonary arterial hypertension: Mendelian randomization with an exploratory NHANES risk-burden analysis. Science Progress. 2026;109(2). doi:10.1177/00368504261463441
BibTeX
@article{He2026,
author = {He, Huabin and Liu, Zhekang and Yu, Qingyun and Fu, Qingan and Zhu, Huangxin},
title = {Genetically predicted serum uric acid and pulmonary arterial hypertension: Mendelian randomization with an exploratory NHANES risk-burden analysis},
journal = {Science Progress},
year = {2026},
volume = {109},
number = {2},
doi = {10.1177/00368504261463441}
}
EUVIMED